Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 20Unknown 9Not yet recruiting 4Recruiting 3Terminated 2Active not recruiting 2

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Breast Neoplasms 1

Interventions

Cyclophosphamide 240Radiotherapy 216Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Rituximab 141Capecitabine 141pembrolizumab 139Oxaliplatin 124Nivolumab 124Dexamethasone 122Fluorouracil 113fludarabine 103Radiosurgery 101Doxorubicin 99fludarabine phosphate 96Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 91Magnetic Resonance Spectroscopy 90Radiation 89Leucovorin 88Filgrastim 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × OTHER × CP protocol × Clear all
NCT04016142 2026-03-18

ACCRAPAN

Centre Oscar Lambret

Phase 2 Terminated
21 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT00912444 2016-11-22

NATT

Shanghai Jiao Tong University School of Medicine

Phase 3 Terminated
102 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡